Viromed Medical AG: Uwe Perbandt's Financial Influence

Viromed Medical AG, a leader in cold plasma technology, acknowledges CEO and founder Uwe Perbandt's pivotal role as a financial backer. From 2023 to 2026, Perbandt and his family contributed approximately EUR 16.6 million, reinforcing Viromed's financial stability and aiding in its strategic expansion.

The financing primarily aimed to bolster working capital and manage existing liabilities. Notably, the financing structure involved complex funding routes, including liability assumptions by the family's holding company and receivables offsets, impacting the company's financial statements presentation.

Perbandt highlighted the funds' significance in facilitating Viromed's capacity to adapt swiftly to scientific and regulatory demands, ensuring the progress of cold plasma technology advancements, particularly for pulmonary applications.